Pharmaceuticals Philippines

Philippines HPV Vaccines Market Analysis, 2024–2034

Philippines HPV Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Type, Gender, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Philippines · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $23.8 Mn Estimated value
Estimate 2025 $25.9 Mn 0.2% of the global market
Projected 2034 $54.8 Mn 111.9% Adds $28.9 Mn over 9 forecast years
CAGR 2025–2034 8.7% Faster than 51% of 180 Pharmaceuticals markets here
Key players 5
  • Philippines is 0.23% of the global market.
  • In APAC, the largest is China at $842.9 Mn.
  • Fastest growing: India at 10.7% a year.
  • Philippines ranks 6th of 10 by size in APAC.

Market size projection

Philippines

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$28.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
HPV Vaccines Market market size by year, Philippines
YearMarket sizeChange that yearSince 2025
2024 (estimate) $23.8 Mn — —
2025 (base) $25.9 Mn +$2.1 Mn —
2026 (forecast) $28.1 Mn +$2.3 Mn +8.7%
2027 (forecast) $30.6 Mn +$2.4 Mn +18.2%
2028 (forecast) $33.2 Mn +$2.7 Mn +28.4%
2029 (forecast) $36.1 Mn +$2.9 Mn +39.6%
2030 (forecast) $39.3 Mn +$3.1 Mn +51.8%
2031 (forecast) $42.7 Mn +$3.4 Mn +65%
2032 (forecast) $46.4 Mn +$3.7 Mn +79.3%
2033 (forecast) $50.4 Mn +$4.0 Mn +94.9%
2034 (forecast) $54.8 Mn +$4.4 Mn +111.9%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $11.08 Bn
  2. North America $6.25 Bn
  3. US $4.47 Bn
  4. APAC $2.23 Bn
  5. Europe $1.77 Bn
  6. Canada $829.7 Mn
  7. China $842.9 Mn
  8. Japan $771.5 Mn
  9. Latin America $443.9 Mn
  10. Middle East $397.6 Mn
  11. Germany $368.3 Mn
  12. UK $300.0 Mn
  13. Italy $284.9 Mn
  14. France $276.5 Mn
  15. Brazil $271.6 Mn
  16. Ecuador $246.0 Mn
  17. Spain $238.8 Mn
  18. India $233.1 Mn
  19. Saudi Arabia $195.1 Mn
  20. Africa $182.3 Mn
  21. Mexico $159.6 Mn
  22. Australia $136.8 Mn
  23. New Zealand $110.3 Mn
  24. Russia $108.2 Mn
  25. South Africa $65.3 Mn
  26. UAE $60.0 Mn
  27. Egypt $27.7 Mn
  28. Philippines (this report) $25.9 Mn
  29. Malaysia $20.6 Mn
  30. Hong Kong $20.2 Mn
  31. Singapore $13.6 Mn
  32. Thailand $12.7 Mn
  33. Kenya $7.1 Mn

The Philippines HPV Vaccines Market Analysis Executive Summary

HPV vaccines protect against human papillomavirus types that cause cervical and other cancers and genital warts.

Key segments of the HPV Vaccines market include type (9-Valent, Bivalent and Quadrivalent) and gender (Female and Male).

Philippines HPV Vaccines Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the HPV Vaccines market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the HPV Vaccines market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the HPV Vaccines market.

Competitive Landscape for HPV Vaccines Market in Philippines

The HPV Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for HPV Vaccines Market in Philippines

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for HPV Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Philippines.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in HPV Vaccines right now, from free public sources.

Latest research 1,087 papers since 2021 (worldwide)

  1. Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria. PloS one, 2026
  2. Therapeutic HPV16 E7 vaccination with CD137 agonism induces tumor regression and durable immunity in mice. iScience, 2026
  3. The role of human papillomavirus in the pathogenesis of oropharyngeal squamous cell carcinoma and the impact of vaccination on disease prevention: a narrative review. The Journal of laryngology and otology, 2026
  4. Rationale and design of randomized, double-blind trial evaluating the efficacy of single-dose HPV vaccine efficacy in women aged 18 to 30: The PRISMA trial. Vaccine, 2026
  5. Age-specific income losses due to HPV-attributable cancers in Singapore. PloS one, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

HPV Vaccines in context

The Philippines compared

  • Health spending per person: 194 US$ per person (2023). World: 1,317 US$ per person (2023). 8th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 0.79 per 1,000 people (2021). World: 1.86 per 1,000 people (2022). 9th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 5.7% of people (2025). World: 10.4% of people (2025). 14th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How much research is published on HPV Vaccines?
PubMed lists 1,087 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about HPV Vaccines in Philippines? Our analysts can size it for your plan. Talk to us See the public data Measles vaccine for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Bioinformatics: Making Sense of Health DataSequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Philippines

See all
Same topic, other categories

Related on vaccines and women's health

See the topic